82 related articles for article (PubMed ID: 8475967)
1. Deoxyribonucleic acid analysis facilitates the pretreatment identification of high-risk endometrial cancer patients.
Podratz KC; Wilson TO; Gaffey TA; Cha SS; Katzmann JA
Am J Obstet Gynecol; 1993 Apr; 168(4):1206-13; discussion 1213-5. PubMed ID: 8475967
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of deoxyribonucleic acid ploidy and S-phase fraction as prognostic parameters in advanced epithelial ovarian carcinoma: a prospective study.
Kaern J; Tropé CG; Kristensen GB; Tveit KM; Pettersen EO
Am J Obstet Gynecol; 1994 Feb; 170(2):479-87. PubMed ID: 8116701
[TBL] [Abstract][Full Text] [Related]
3. Deoxyribonucleic acid analysis by flow cytometry of uterine leiomyosarcomas and smooth muscle tumors of uncertain malignant potential.
Peters WA; Howard DR; Andersen WA; Figge DC
Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 1):1646-53; discussion 1653-4. PubMed ID: 1615971
[TBL] [Abstract][Full Text] [Related]
4. Deoxyribonucleic acid ploidy and S-phase fraction are not significant prognostic factors for patients with cervical cancer.
Jelen I; Valente PT; Gautreaux L; Clark GM
Am J Obstet Gynecol; 1994 Dec; 171(6):1511-6; discussion 1516-8. PubMed ID: 7802060
[TBL] [Abstract][Full Text] [Related]
5. Prospective analysis of DNA ploidy, proliferative index and epidermal growth factor receptor as prognostic factors for pretreated uterine cancer.
Nagai N; Oshita T; Fujii T; Kioka H; Katsube Y; Ohama K
Oncol Rep; 2000; 7(3):551-9. PubMed ID: 10767367
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric analysis of DNA ploidy, percent S-phase fraction, and total proliferative fraction as prognostic indicators of local control and survival following radiation therapy for prostate carcinoma.
Centeno BA; Zietman AL; Shipley WU; Sobczak ML; Shipley JW; Preffer FI; Boyle BJ; Colvin RB
Int J Radiat Oncol Biol Phys; 1994 Sep; 30(2):309-15. PubMed ID: 7928459
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric measurements of DNA index and S-phase on paraffin-embedded early stage endometrial cancer: an important prognostic indicator.
Rosenberg P; Wingren S; Simonsen E; Stàl O; Risberg B; Nordenskjöld B
Gynecol Oncol; 1989 Oct; 35(1):50-4. PubMed ID: 2792902
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric DNA analysis of stage I endometrial carcinoma.
Britton LC; Wilson TO; Gaffey TA; Lieber MM; Wieand HS; Podratz KC
Gynecol Oncol; 1989 Sep; 34(3):317-22. PubMed ID: 2767522
[TBL] [Abstract][Full Text] [Related]
9. Molecular and cytokinetic pretreatment risk assessment in endometrial carcinoma.
Silverman MB; Roche PC; Kho RM; Keeney GL; Li H; Podratz KC
Gynecol Oncol; 2000 Apr; 77(1):1-7. PubMed ID: 10739683
[TBL] [Abstract][Full Text] [Related]
10. DNA ploidy in endometrial carcinoma: major objective prognostic factor.
Britton LC; Wilson TO; Gaffey TA; Cha SS; Wieand HS; Podratz KC
Mayo Clin Proc; 1990 May; 65(5):643-50. PubMed ID: 2348728
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric deoxyribonucleic acid index: a prognostic factor in endometrial carcinoma.
Iversen OE
Am J Obstet Gynecol; 1986 Oct; 155(4):770-6. PubMed ID: 3766632
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of flow cytometric deoxyribonucleic acid index in endometrial carcinoma: comparison with other clinical-pathologic parameters.
Susini T; Rapi S; Savino L; Boddi V; Berti P; Massi G
Am J Obstet Gynecol; 1994 Feb; 170(2):527-34. PubMed ID: 8116708
[TBL] [Abstract][Full Text] [Related]
13. DNA ploidy in curettage specimens identifies high-risk patients and lymph node metastasis in endometrial cancer.
Njølstad TS; Trovik J; Hveem TS; Kjæreng ML; Kildal W; Pradhan M; Marcickiewicz J; Tingulstad S; Staff AC; Haugland HK; Eraker R; Oddenes K; Rokne JA; Tjugum J; Lode MS; ; Amant F; Werner HM; Salvesen HB; Danielsen HE
Br J Cancer; 2015 May; 112(10):1656-64. PubMed ID: 25897678
[TBL] [Abstract][Full Text] [Related]
14. Malignant mixed Müllerian tumors of the uterus: a clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 44 cases.
Blom R; Guerrieri C; Stâl O; Malmström H; Sullivan S; Simonsen E
Gynecol Oncol; 1998 Jan; 68(1):18-24. PubMed ID: 9454654
[TBL] [Abstract][Full Text] [Related]
15. Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results.
Tsang RW; Fyles AW; Kirkbride P; Levin W; Manchul LA; Milosevic MF; Rawlings GA; Banerjee D; Pintilie M; Wilson GD
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1319-29. PubMed ID: 7635771
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment assessment of prognostic indicators in endometrial cancer.
Mariani A; Sebo TJ; Katzmann JA; Keeney GL; Roche PC; Lesnick TG; Podratz KC
Am J Obstet Gynecol; 2000 Jun; 182(6):1535-44. PubMed ID: 10871476
[TBL] [Abstract][Full Text] [Related]
17. Flow-cytometric analysis of deoxyribonucleic acid content in advanced ovarian carcinoma: its importance in long-term survival.
Zanetta G; Keeney GL; Cha SS; Farr GH; Katzmann JA; Wieand HS; Edmonson JH; Podratz KC
Am J Obstet Gynecol; 1996 Nov; 175(5):1217-25. PubMed ID: 8942491
[TBL] [Abstract][Full Text] [Related]
18. DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas.
Dolan JR; McCall AR; Gooneratne S; Walter S; Lansky DM
Gynecol Oncol; 1993 Feb; 48(2):232-5. PubMed ID: 8428696
[TBL] [Abstract][Full Text] [Related]
19. Value of DNA ploidy and S-phase fraction as prognostic factors in stage III cutaneous melanoma.
Martin G; Halwani F; Shibata H; Meterissian S
Can J Surg; 2000 Feb; 43(1):29-34. PubMed ID: 10714254
[TBL] [Abstract][Full Text] [Related]
20. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]